Resum
In silico screening of a collection of 1584 academic compounds identified a small molecule hit for the human adenosine A2A receptor (pK i = 6.2) containing a novel chromene scaffold (3a). To explore the structure-activity relationships of this new chemical series for adenosine receptors, a focused library of 43 2H-chromene-3-carboxamide derivatives was synthesized and tested in radioligand binding assays at human adenosine A 1, A2A, A2B and A3 receptors. The series was found to be enriched with bioactive compounds for adenosine receptors, with 14 molecules showing submicromolar affinity (pKi ≥ 6.0) for at least one adenosine receptor subtype. These results provide evidence that the chromene scaffold, a core structure present in natural products from a wide variety of plants, vegetables, and fruits, constitutes a valuable source for novel therapeutic agents.
| Idioma original | Anglès |
|---|---|
| Pàgines (de-a) | 303-310 |
| Nombre de pàgines | 8 |
| Revista | European Journal of Medicinal Chemistry |
| Volum | 54 |
| DOIs | |
| Estat de la publicació | Data de publicació - d’ag. 2012 |
| Publicat externament | Sí |
Fingerprint
Navegar pels temes de recerca de 'New chromene scaffolds for adenosine A2A receptors: Synthesis, pharmacology and structure-activity relationships'. Junts formen un fingerprint únic.Com citar-ho
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver